Legal Opinion
Daiichi Sankyo Co., Ltd. v. MATRIX LABORATORIES
Court of Appeals for the Federal Circuit
Decided September 9, 2010No. 2009-1511PublishedCited by 17 opinions
1Opinion of the Court
LOURIE, Circuit Judge.
Matrix Laboratories, Ltd., Mylan Inc., Mylan Laboratories, Inc., and Mylan Pharmaceuticals, Inc. (collectively, “Mylan”) appeal from the final decision of the United States District Court for the District of New Jersey sustaining the validity of U.S. Patent 5,616,599 (“the '599 patent”) under 35 U.S.C. § 103. We affirm.
BACKGROUND
I
Daiichi Sankyo Company, Ltd. and Daii-chi Sankyo, Inc. (collectively, “Daiichi”) own the '599 patent, which claims 1-biphe-nylmethylimidazole compounds and their use as angiotensin receptor blockers (“ARBs”) for the treatment of high blood…
2Cases cited11 opinions
- United States v. United States Gypsum Co.Supreme Court of the United States · 1948
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Ortho-McNeil Pharmaceutical, Inc. v. Mylan Laboratories, Inc.Court of Appeals for the Federal Circuit · 2008
- Takeda Chemical Industries, Ltd. v. Alphapharm Pty., Ltd.Court of Appeals for the Federal Circuit · 2007
6 more not listed; retrieve them via the Exa API.
3Cited by17 opinions
- OTSUKA PHARMACEUTICAL CO., LTD. v. Sandoz, Inc.Court of Appeals for the Federal Circuit · 2012
- Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2014
- Cheese Systems, Inc. v. Tetra Pak Cheese & Powder Systems, Inc.Court of Appeals for the Federal Circuit · 2013
- Anacor Pharmaceuticals, Inc. v. IancuCourt of Appeals for the Federal Circuit · 2018
- Bristol-Myers Squibb Co. v. Teva Pharmaceuticals USA, Inc.District Court, D. Delaware · 2013
12 more not listed; retrieve them via the Exa API.